G. Patel

The role of second autografts in the management of myeloma at first relapse.

G. Morgan, F. Davies, R. Powles, 2006, Haematologica.

1575P Systemic anti-cancer therapy and metastatic cancer are independent mortality risk factors during two UK waves of the COVID-19 pandemic at University College London Hospital

R. Roylance, D. Ottaviani, E. Merry, 2021, Annals of Oncology.

Long‐term outcomes of previously untreated myeloma patients: responses to induction chemotherapy and high‐dose melphalan incorporated within a risk stratification model can help to direct the use of novel treatments

G. Morgan, C. Dearden, F. Davies, 2005, British journal of haematology.